Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
12.39
-0.11 (-0.88%)
Feb 19, 2026, 4:00 PM EST - Market closed
Tenax Therapeutics Market Cap
Tenax Therapeutics has a market cap or net worth of $502.67 million as of February 19, 2026. Its market cap has increased by 2,376.19% in one year.
Market Cap
502.67M
Enterprise Value
407.76M
1-Year Change
2,376.19%
Ranking
Category
Stock Price
$12.39
Market Cap Chart
Since January 15, 2010, Tenax Therapeutics's market cap has increased from $148.50M to $502.67M, an increase of 238.50%. That is a compound annual growth rate of 7.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 78.00M | 2.50% |
| Dec 31, 2025 | 76.10M | 260.66% |
| Dec 31, 2024 | 21.10M | 219.70% |
| Dec 29, 2023 | 6.60M | 32.00% |
| Dec 30, 2022 | 5.00M | -80.92% |
| Dec 31, 2021 | 26.20M | 11.49% |
| Dec 31, 2020 | 23.50M | 147.37% |
| Dec 31, 2019 | 9.50M | 427.78% |
| Dec 31, 2018 | 1.80M | -86.96% |
| Dec 29, 2017 | 13.80M | -74.82% |
| Dec 30, 2016 | 54.80M | -40.63% |
| Dec 31, 2015 | 92.30M | -14.54% |
| Dec 31, 2014 | 108.00M | 125.94% |
| Dec 31, 2013 | 47.80M | 123.36% |
| Dec 31, 2012 | 21.40M | -45.69% |
| Dec 30, 2011 | 39.40M | -10.86% |
| Dec 31, 2010 | 44.20M | -70.24% |
| Jan 15, 2010 | 148.50M | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vor Biopharma | 548.06M |
| Forte Biosciences | 521.21M |
| Lyell Immunopharma | 518.14M |
| ADC Therapeutics | 511.61M |
| Allogene Therapeutics | 510.14M |
| Ginkgo Bioworks Holdings | 508.68M |
| Gossamer Bio | 502.26M |
| Keros Therapeutics | 492.64M |